ENRICH Ibrutinib for untreated mantle cell lymphoma

Trial description
Randomised, open label study of rituximab/ibrutinib vs rituximab/chemotherapy in older patients with untreated mantle cell lymphoma
Contact name
Dr George Follows
Trial start date
Thursday, May 14, 2020
Trial end date
Thursday, March 31, 2022
Trial tumour type
Haematological
Show on Radiotherapy
No